Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025

Rhea-AI Summary

Krystal Biotech (NASDAQ: KRYS) will report third quarter 2025 financial results on Monday, November 3, 2025, before the U.S. market open. Management will host a conference call and webcast at 8:30 am ET on November 3 to discuss results and provide a business update.

Investors can access the live webcast at https://www.webcaster5.com/Webcast/Page/3018/53113. A replay will be available for at least 30 days on the Investors section of the company website at www.krystalbio.com.

PITTSBURGH, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that it will report its third quarter 2025 financial results on Monday, November 3, 2025, prior to the open of U.S. markets.

The Company’s management will also host a conference call and webcast at 8:30 am ET on Monday, November 3, 2025, to discuss the financial results and provide a business update.

Investors and the general public can access the live webcast at: https://www.webcaster5.com/Webcast/Page/3018/53113.

For those unable to listen to the live webcast, a replay will be available for at least 30 days on the Investors section of the Company’s website at www.krystalbio.com.

About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK^®, the Company’s first commercial product, is the first-ever redosable gene therapy, and the first genetic medicine approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).

CONTACT
Investors and Media:                                                             
Stéphane Paquette, PhD
Krystal Biotech
spaquette@krystalbio.com

FAQ

When will Krystal Biotech (KRYS) report Q3 2025 results?

Krystal Biotech will report Q3 2025 financial results on Monday, November 3, 2025, prior to the U.S. market open.

What time is the Krystal Biotech (KRYS) earnings call on November 3, 2025?

The company will host a conference call and webcast at 8:30 am ET on November 3, 2025.

Where can I watch the Krystal Biotech (KRYS) live webcast for Q3 2025?

Watch the live webcast at https://www.webcaster5.com/Webcast/Page/3018/53113.

Will Krystal Biotech (KRYS) provide a replay of the Q3 2025 webcast?

Yes. A replay will be available for at least 30 days on the Investors section of www.krystalbio.com.

How can investors access the Krystal Biotech (KRYS) business update on November 3, 2025?

Investors can join the 8:30 am ET conference call/webcast on November 3, 2025 via the live webcast link or listen via the company investor site replay.